Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
AI Prime
company
About
AI Prime is a life sciences company focused on developing oncology therapeutics targeting the growth and proliferation of cancer cells.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Artificial Intelligence
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
AI Prime has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jun 6, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 6, 2022 | Series A | — | 1 |
|
— | Detail |
| Jul 1, 2020 | Seed | — | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
AI Prime is funded by 3 investors.
Suzhou Zhongxin Innovation Investment Management
and Zhidao Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
|
— | Seed |
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
